Key facts
- Kangjie Medical’s last known valuation is $18.4M (Jan 2025).
- It has raised $5.5M; the latest was Later Stage VC ($2.0M) in Jan 2025.
- Notable investors include Anhui Lianyuan Venture Capital, Dingqi Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Kangjie Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Kangjie Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kangjie Medical
Developer of medical devices designed for ophthalmology. The company's products mainly focus on R&D, production and sales of slit lamp microscopes, retinoscopes, ophthalmoscopes and other ophthalmic medical devices, which can be applied in the fields of eye hospitals, ophthalmology clinics, optometry centers, maternal and child hospitals, etc., providing customers with reliable and innovative products.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 1998
- Employees
- 77
- Website
- szkjyl.com/
- Ownership
- Privately Held (backing)
Kangjie Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kangjie Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kangjie Medical in its N-PORT filings yet. We sweep new filings monthly.